scispace - formally typeset
R

Robin M. Murray

Researcher at King's College London

Publications -  1583
Citations -  128883

Robin M. Murray is an academic researcher from King's College London. The author has contributed to research in topics: Psychosis & Schizophrenia. The author has an hindex of 171, co-authored 1539 publications receiving 116362 citations. Previous affiliations of Robin M. Murray include University of Cambridge & National Institutes of Health.

Papers
More filters
Journal ArticleDOI

Effects of long-term prolactin-raising antipsychotic medication on bone mineral density in patients with schizophrenia

TL;DR: Patients with schizophrenia on long-term prolactin-raising antipsychotic medication are at high risk of developing reduced bone mineral density as a consequence of hyperprolactinaemia-induced hypogonadism.
Journal ArticleDOI

Sex and schizophrenia: effects of diagnostic stringency, and associations with and premorbid variables.

TL;DR: The results suggest that schizophrenia syndrome is heterogeneous, and young males are especially prone to a severe neurodevelopmental form of illness associated with premorbid deficits.
Journal ArticleDOI

Clozapine, single photon emission tomography, and the D2 dopamine receptor blockade hypothesis of schizophrenia.

TL;DR: Clinical response with central D2 dopamine receptor availability measured by 123I-iodobenzamide single photon emission tomography in two groups of schizophrenic patients suggests a more complex relation between D2 blockade and clinical efficacy than was previously thought.
Journal ArticleDOI

Neighbourhood-level effects on psychoses: re-examining the role of context.

TL;DR: SERFs at individual and neighbourhood levels were implicated in the aetiology of psychosis, but it was unable to determine whether these associations were causal.
Journal ArticleDOI

Pituitary Volume Predicts Future Transition to Psychosis in Individuals at Ultra-High Risk of Developing Psychosis

TL;DR: In this paper, the authors examined pituitary volume before the onset of psychosis in subjects who were at ultra-high risk (UHR) for developing psychosis and found that a larger baseline volume was a significant predictor of future transition to psychosis.